Compounds

LyondellBasell to Acquire Mepol Group

LyondellBasell has entered into a definitive agreement to acquire Mepol Group, a manufacturer of recycled, high-performing engineering compounds based in Italy and Poland.

News

Biosynthesis of Heterocycles

Top-Feature

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.